NLRC4 and metabolic dysfunction-associated steatotic liver disease: More importantly, this study explored the role of NLRC4 and interleukin (IL)-1β in the growth of metastatic liver tumors under NAFLD-related liver microenvironment, emphasizing the effect of inflammation changes in NAFLD on the metastatic microenvironment.